Second, high-diversity, highly abundant BCR repertoire is not restricted to SKCM that bear high somatic mutation burden, suggesting that B cells can infiltrate melanoma in response to other antigens, such as melanoma differentiation and cancer testis antigens [17], viral antigens, and/or potentially other factors such as B cell chemotactic cytokines. This evidence concerns the gene BCR and cancer.